Evidence map›Paper›PMID 36504711›Full record

ArticleFrontiers in molecular biosciences2022

Endothelial-mesenchymal transition induced by metastatic 4T1 breast cancer cells in pulmonary endothelium in aged mice.

Marta Smeda, Agnieszka Jasztal, Ebrahim H Maleki, Anna Bar, Magdalena Sternak, Grzegorz Kwiatkowski, Joanna Suraj-Prażmowska, Bartosz Proniewski, Anna Kieronska-Rudek, Kamila Wojnar-Lason and 5 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Marta SmedaJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Agnieszka JasztalJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Ebrahim H MalekiJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Anna BarJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Magdalena SternakJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Grzegorz KwiatkowskiJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Joanna Suraj-PrażmowskaJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Bartosz ProniewskiJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Anna Kieronska-RudekJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Kamila Wojnar-LasonJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Klaudia SkrzypekDepartment of Transplantation, Faculty of Medicine, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
Marcin MajkaDepartment of Transplantation, Faculty of Medicine, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
Karolina ChrabaszczFaculty of Chemistry, Jagiellonian University in Krakow, Krakow, Poland.
Kamilla MalekFaculty of Chemistry, Jagiellonian University in Krakow, Krakow, Poland.
Stefan ChlopickiJagiellonian Centre for Experimental Therapeutics (JCET), Jagiellonian University, Krakow, Poland.
Jagiellonian University · PLInstitute of Nuclear Physics, Polish Academy of Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ageing is a major risk factor for cancer metastasis but the underlying mechanisms remain unclear. Here, we characterised ageing effects on cancer-induced endothelial-mesenchymal transition (EndMT) in the pulmonary circulation of female BALB/c mice in a metastatic 4T1 breast cancer model. The effect of intravenously injected 4T1 cells on pulmonary endothelium, pulmonary metastasis, lung tissue architecture, and systemic endothelium was compared between 40-week-old and 20-week-old mice. The 40-week-old mice showed features of ongoing EndMT in their lungs before 4T1 breast cancer cell injection. Moreover, they had preexisting endothelial dysfunction in the aorta detected by

Indexed as

ageingage-related endothelial dysfunctionbreast cancer metastasisendothelial-mesenchymal transitionRaman spectroscopy

Identifiers

PMID36504711
PMCPMC9731229
OpenAlexW4309899348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.